Skip to main content
. 2022 Jun 17;71(9):1994–2008. doi: 10.2337/db22-0177

Table 1.

Plasma concentrations of RAGE ligands in NOD/ShiLt mice

Treatment Day 64 of life Day 225 of life
Vehicle sRAGE Vehicle sRAGE
CML (nmol/mmol Lys) 32.2 (3.5) 31.1 (3.7) 76.5 (10.6) 71.1 (12.4)*
CEL (nmol/mmol Lys) 13.5 (4.0) 16.2 (8.0) 15.4 (3.8) 12.3 (4.2)*
MG-H1 (nmol/mmol Lys) 229.3 (45.1) 260.1 (56.4) 267.7 (39.5) 247.0 (54.6)*
MGO (nmol/L) 499.5 (78.8) 436.4 (142.9) 643.7 (280.2) 556.1 (246.4)
GO (nmol/L) 848.4 (301.8) 958.3 (316.0) 1,083.0 (505.2) 1,004.0 (518.5)
3-DG (nmol/L) 987.3 (254.7) 1,163.0 (401.0) 2,547.0 (476.0) 2,227.0 (483.0)
S100A8 (ng/mL) 0.5 (0.1) 7.1 (23.0) 5.3 (13.1) 5.0 (26.0)
S100A9 (ng/mL) 166.8 (131.8) 301.3 (303.0) 74.9 (144.3) 100.5 (81.8)
S100B (ng/mL) 1,081.0 (812.9) 882.5 (512.7) 1,052.0 (528.8) 1,077.0 (545.6)
HMGB1 (ng/mL) 11.9 (7.5) 15.8 (8.2) 7.1 (3.7) 5.7 (5.0)

Data shown as median (IQR), with analysis with two-tailed Mann-Whitney U test. n = 12–15/group. 3-DG, 3-deoxyglucosone; GO, glyoxal; Lys, lysine; MGO, methylglyoxal.

*

P < 0.05 vs. vehicle at same time point.